Sellas Life Sciences Group Inc. has announced the extension of its sublease agreement for its premises at Times Square Tower, located at 7 Times Square, New York, New York. Under the terms of a recently executed Letter Agreement with Times Square Tower Associates LLC, the expiration date of the sublease has been extended from September 30, 2026, to September 30, 2027. The annual rent for the premises remains unchanged. Further details of the agreement are available in the company's regulatory filing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sellas Life Sciences Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-096643), on October 03, 2025, and is solely responsible for the information contained therein.